Journal of Asthma and Allergy
Volume 14, 2021 - Issue
Open access
186
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study
Soichiro Hozawa1 Hiroshima Allergy and Respiratory Clinic, Hiroshima, Japan
, Hiroyuki Ohbayashi2 Tohno Chuo Clinic, Gifu, Japanhttps://orcid.org/0000-0002-5186-8761
, Michiko Tsuchiya3 Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan
, Yu Hara4 Department of Pulmonology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan
, Laurie A Lee5 GSK, Collegeville, PA, USA
, Takashi Nakayama6 GSK, Tokyo, Japanhttps://orcid.org/0000-0003-1948-6373
, Jun Tamaoki6 GSK, Tokyo, Japan
, Andrew Fowler7 GSK, Brentford, Middlesex, UK
& Takanobu Nishi6 GSK, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-2272-6833
show allhttps://orcid.org/0000-0003-2272-6833
Pages 809-819
|
Published online: 06 Jul 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.